"Myopic drug" low concentration atropine eye drops suspended online sale

2022-07-28

Recently, Shenyang Xingqi Eye Hospital, a wholly-owned subsidiary of Xingqi eye medicine, announced that since July 22, the Internet hospital has suspended the prescription of 0.01% atropine sulfate eye drops, and patients can go to physical hospitals to prescribe if necessary.


This announcement confirmed the news that the hospital preparations of low concentration atropine, which had been widely spread before, were about to stop selling on the Internet.

On the 22nd, a number of eye companies, including Xingqi eye medicine, he's ophthalmology and OPEC, said that the sales of 0.01% atropine sulfate eye drops had been suspended in Internet hospitals.


After the news came out, many parents of myopic children said on social platforms that they "urgently need to stock up".


What is atropine eye drops behind hot search


Data show that atropine eye drops is an M-cholinergic receptor inhibitor, which was previously used to rescue organophosphorus poisoning, anesthesia, mydriasis and the treatment of iritis. As early as the 1970s, there were reports about the application of atropine eye drops in myopia prevention and control.


image.png


So far, atropine eye drops is still the only drug that has been verified by evidence-based medicine to effectively delay the progression of myopia.


At the same time, compared with high concentration atropine eye drops, 0.01% atropine eye drops has the least adverse reactions and the least rebound effect after drug withdrawal. The study indicates that the myopia prevention and control effect of 0.01% atropine eye drops can reach 27%~83%.


Use in hospital preparation


It can also be obtained through Internet hospitals


According to the national drug clinical trial registration and information publicity platform, there are currently 8 clinical trials of "atropine sulfate eye drops" under way, and most of their indications are "delaying the progress of myopia in children".


Up to now, the application of low concentration atropine eye drops for myopia prevention and control has not been officially approved by the National Drug Administration for clinical use in China, but has been used in some provinces in the form of in-hospital preparations approved by the provincial drug administration under conditions in the hospital. Previously, some children can also be obtained through Internet hospitals with prescriptions issued by doctors.


image.png


In China, many parents are keen to buy atropine eye drops, making atropine a net red eye drops. In December last year, Henan's first in-hospital preparation to inhibit the development of myopia in children and adolescents, 0.01% atropine sulfate eye drops, was approved for sale in Henan Provincial People's hospital. As soon as the news came out, parents queued up to buy eye drops.


Atropine eye drops suspended Online


What is the reality


The online sale of atropine eye drops, the "magic medicine for myopia", has been suspended. What is the reality?


Open Taobao and jd.com, search for "atropine sulfate eye drops", and find the news that Xingqi low concentration 0.01% atropine sulfate eye drops that have been stopped selling in Internet hospitals have been completely unavailable on various platforms, only atropine eye drops from other countries, such as India and Switzerland.